Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Nat Commun ; 15(1): 6980, 2024 Aug 14.
Article de Anglais | MEDLINE | ID: mdl-39143045

RÉSUMÉ

Antibiotics may alter the gut microbiome, and this is one of the mechanisms by which antimicrobial resistance may be promoted. Suboptimal antimicrobial stewardship in Asia has been linked to antimicrobial resistance. We aim to examine the relationship between oral antibiotic use and composition and antimicrobial resistance in the gut microbiome in 1093 Bangladeshi infants. We leverage a trial of 8-month-old infants in rural Bangladesh: 61% of children were cumulatively exposed to antibiotics (most commonly cephalosporins and macrolides) over the 12-month study period, including 47% in the first 3 months of the study, usually for fever or respiratory infection. 16S rRNA amplicon sequencing in 11-month-old infants reveals that alpha diversity of the intestinal microbiome is reduced in children who received antibiotics within the previous 7 days; these samples also exhibit enrichment for Enterococcus and Escherichia/Shigella genera. No effect is seen in children who received antibiotics earlier. Using shotgun metagenomics, overall abundance of antimicrobial resistance genes declines over time. Enrichment for an Enterococcus-related antimicrobial resistance gene is observed in children receiving antibiotics within the previous 7 days, but not earlier. Presence of antimicrobial resistance genes is correlated to microbiome composition. In Bangladeshi children, community use of antibiotics transiently reprofiles the gut microbiome.


Sujet(s)
Antibactériens , Microbiome gastro-intestinal , ARN ribosomique 16S , Humains , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Microbiome gastro-intestinal/génétique , Bangladesh/épidémiologie , Nourrisson , Antibactériens/administration et posologie , Antibactériens/pharmacologie , ARN ribosomique 16S/génétique , Mâle , Femelle , Administration par voie orale , Résistance bactérienne aux médicaments/génétique , Fèces/microbiologie , Métagénomique/méthodes , Bactéries/génétique , Bactéries/effets des médicaments et des substances chimiques , Bactéries/classification , Bactéries/isolement et purification , Céphalosporines/administration et posologie , Céphalosporines/pharmacologie , Céphalosporines/usage thérapeutique , Enterococcus/effets des médicaments et des substances chimiques , Enterococcus/génétique , Enterococcus/isolement et purification , Gestion responsable des antimicrobiens
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE